Financial Ratios Numinus Wellness Inc. Toronto S.E.
Equities
NUMI
CA67054W1032
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0500 CAD | -.--% |
|
-.--% | - |
| Fiscal Period: August | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Profitability | |||||||
Return on Assets | -110.97 | -28.59 | -30.45 | -42.87 | -42.43 | ||
Return on Total Capital | -188.34 | -30.16 | -31.9 | -46.92 | -62.05 | ||
Return On Equity % | -460.92 | -59.01 | -87.97 | -109.5 | -197.64 | ||
Return on Common Equity | -460.92 | -59.01 | -87.97 | -109.5 | -197.64 | ||
Margin Analysis | |||||||
Gross Profit Margin % | 9.41 | -5.39 | 27.36 | 36.11 | 27.97 | ||
SG&A Margin | 571.81 | 798.84 | 368.11 | 127.38 | 282.66 | ||
EBITDA Margin % | -776.2 | -1.02K | -429.28 | -109.58 | -274.36 | ||
EBITA Margin % | -826.43 | -1.05K | -437.55 | -113.54 | -285.89 | ||
EBIT Margin % | -826.43 | -1.05K | -438.1 | -113.87 | -285.89 | ||
Income From Continuing Operations Margin % | -1.09K | -1.24K | -691.12 | -130.53 | -350.24 | ||
Net Income Margin % | -1.09K | -1.24K | -691.12 | -130.53 | -471.23 | ||
Net Avail. For Common Margin % | -1.09K | -1.24K | -691.12 | -130.53 | -350.24 | ||
Normalized Net Income Margin | -524.68 | -660.28 | -277.01 | -74.83 | -179.39 | ||
Levered Free Cash Flow Margin | -292.29 | -601.78 | -216.75 | -56.52 | -140.38 | ||
Unlevered Free Cash Flow Margin | -282.11 | -597.07 | -211.38 | -54.47 | -138.9 | ||
Asset Turnover | |||||||
Asset Turnover | 0.21 | 0.04 | 0.11 | 0.6 | 0.24 | ||
Fixed Assets Turnover | 0.35 | 0.54 | 0.89 | 2.19 | 0.78 | ||
Receivables Turnover (Average Receivables) | 6.31 | 11.62 | 8.99 | 14.62 | 3.29 | ||
Inventory Turnover (Average Inventory) | - | - | - | - | - | ||
Short Term Liquidity | |||||||
Current Ratio | 1.33 | 31.88 | 7.88 | 2.6 | 1.14 | ||
Quick Ratio | 1.08 | 31.27 | 7.56 | 2.27 | 0.33 | ||
Operating Cash Flow to Current Liabilities | -2.67 | -8.14 | -5.72 | -4.9 | -1.44 | ||
Days Sales Outstanding (Average Receivables) | 58.01 | 31.42 | 40.6 | 24.97 | 111.15 | ||
Days Outstanding Inventory (Average Inventory) | - | - | - | - | - | ||
Average Days Payable Outstanding | - | - | - | 68.97 | 299.38 | ||
Long Term Solvency | |||||||
Total Debt/Equity | 15.06 | 2.64 | 19.05 | 51.25 | 280.32 | ||
Total Debt / Total Capital | 13.09 | 2.57 | 16 | 33.88 | 73.71 | ||
LT Debt/Equity | 11.28 | 1.97 | 15.55 | 40.16 | 198.64 | ||
Long-Term Debt / Total Capital | 9.8 | 1.92 | 13.06 | 26.55 | 52.23 | ||
Total Liabilities / Total Assets | 45.36 | 5.17 | 21.69 | 42.26 | 93.27 | ||
EBIT / Interest Expense | -50.74 | -138.75 | -51.01 | -34.75 | -120.65 | ||
EBITDA / Interest Expense | -46.46 | -132.47 | -48.31 | -31.01 | -100.03 | ||
(EBITDA - Capex) / Interest Expense | -46.71 | -138.09 | -50.54 | -31.51 | -100.29 | ||
Total Debt / EBITDA | -0.06 | -0.11 | -0.29 | -0.31 | -0.21 | ||
Net Debt / EBITDA | 0.18 | 3.81 | 0.94 | 0.06 | -0.01 | ||
Total Debt / (EBITDA - Capex) | -0.06 | -0.1 | -0.28 | -0.3 | -0.21 | ||
Net Debt / (EBITDA - Capex) | 0.18 | 3.66 | 0.89 | 0.06 | -0.01 | ||
Growth Over Prior Year | |||||||
Total Revenues, 1 Yr. Growth % | 719.87 | 71.78 | 329.03 | 256.95 | 11.08 | ||
Gross Profit, 1 Yr. Growth % | -114.91 | -198.29 | -2.28K | 371.16 | -26.81 | ||
EBITDA, 1 Yr. Growth % | 10.97 | 126.24 | 80.15 | -8.88 | -46.71 | ||
EBITA, 1 Yr. Growth % | 8.64 | 117.53 | 79.37 | -7.37 | -46.75 | ||
EBIT, 1 Yr. Growth % | 8.64 | 117.53 | 79.6 | -7.22 | -46.93 | ||
Earnings From Cont. Operations, 1 Yr. Growth % | 32.08 | 95.55 | 139.06 | -32.59 | -37.17 | ||
Net Income, 1 Yr. Growth % | 32.08 | 95.55 | 139.06 | -32.59 | -35.08 | ||
Normalized Net Income, 1 Yr. Growth % | 9.52 | 116.17 | 80.12 | -3.57 | -47.93 | ||
Diluted EPS Before Extra, 1 Yr. Growth % | 49.21 | -24.35 | 53.89 | -44.62 | -43.88 | ||
Accounts Receivable, 1 Yr. Growth % | 226.68 | -78.15 | 2.89K | 26.85 | -57.23 | ||
Inventory, 1 Yr. Growth % | - | - | - | - | - | ||
Net Property, Plant and Equip., 1 Yr. Growth % | -7.37 | 29.21 | 261.44 | -13.96 | -90.21 | ||
Total Assets, 1 Yr. Growth % | 66.37 | 1.15K | -17.95 | -53.77 | -55.73 | ||
Tangible Book Value, 1 Yr. Growth % | 104.9 | 2.07K | -36.38 | -63.7 | -94.84 | ||
Common Equity, 1 Yr. Growth % | 104.9 | 2.07K | -32.25 | -65.91 | -94.84 | ||
Cash From Operations, 1 Yr. Growth % | 42.41 | 190.89 | 68.37 | -13.23 | -45.37 | ||
Capital Expenditures, 1 Yr. Growth % | -95.98 | 1.72K | 94.15 | -69.88 | -89.02 | ||
Levered Free Cash Flow, 1 Yr. Growth % | 64 | 253.67 | 54.53 | -6.92 | -51.23 | ||
Unlevered Free Cash Flow, 1 Yr. Growth % | 61.6 | 263.56 | 51.89 | -8.01 | -51.32 | ||
Compound Annual Growth Rate Over Two Years | |||||||
Total Revenues, 2 Yr. CAGR % | -44.02 | 275.28 | 171.47 | 291.33 | -19.88 | ||
Gross Profit, 2 Yr. CAGR % | -60.19 | -61.72 | 362.79 | 913.26 | -18.99 | ||
EBITDA, 2 Yr. CAGR % | 68.72 | 58.45 | 101.89 | 28.12 | -35.95 | ||
EBITA, 2 Yr. CAGR % | 65.26 | 53.73 | 97.53 | 28.9 | -35.24 | ||
EBIT, 2 Yr. CAGR % | 65.26 | 53.73 | 97.66 | 29.08 | -35.28 | ||
Earnings From Cont. Operations, 2 Yr. CAGR % | 86.02 | 60.71 | 116.22 | 26.95 | -42.97 | ||
Net Income, 2 Yr. CAGR % | 86.02 | 60.71 | 116.22 | 26.95 | -33.84 | ||
Normalized Net Income, 2 Yr. CAGR % | 66.56 | 53.86 | 97.25 | 31.79 | -35.53 | ||
Diluted EPS Before Extra, 2 Yr. CAGR % | 91.99 | 6.25 | 7.9 | 0.41 | -51.14 | ||
Accounts Receivable, 2 Yr. CAGR % | - | -15.51 | 155.68 | 516 | -26.35 | ||
Inventory, 2 Yr. CAGR % | - | -29.45 | - | - | - | ||
Net Property, Plant and Equip., 2 Yr. CAGR % | 1.36 | 9.4 | 116.11 | 76.34 | -70.98 | ||
Total Assets, 2 Yr. CAGR % | 36.96 | 356.39 | 220.5 | -38.41 | -54.76 | ||
Tangible Book Value, 2 Yr. CAGR % | 24.72 | 567.25 | 271.8 | -51.94 | -86.31 | ||
Common Equity, 2 Yr. CAGR % | 24.72 | 567.25 | 283.69 | -51.94 | -86.73 | ||
Cash From Operations, 2 Yr. CAGR % | 99.69 | 103.53 | 121.31 | 20.87 | -31.15 | ||
Capital Expenditures, 2 Yr. CAGR % | -85.86 | -14.33 | 495.04 | -23.52 | -85.7 | ||
Levered Free Cash Flow, 2 Yr. CAGR % | - | 140.84 | 133.78 | 19.93 | -35.52 | ||
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | 142.39 | 134.99 | 18.2 | -35.05 | ||
Compound Annual Growth Rate Over Three Years | |||||||
Total Revenues, 3 Yr. CAGR % | - | -18.65 | 292.4 | 197.41 | 40.17 | ||
Gross Profit, 3 Yr. CAGR % | - | -46.2 | 47.26 | 365.56 | 142.73 | ||
EBITDA, 3 Yr. CAGR % | - | 86.05 | 65.38 | 54.86 | -9.59 | ||
EBITA, 3 Yr. CAGR % | - | 81.12 | 61.84 | 53.46 | -9.05 | ||
EBIT, 3 Yr. CAGR % | - | 81.12 | 61.91 | 53.61 | -9.05 | ||
Earnings From Cont. Operations, 3 Yr. CAGR % | - | 89.14 | 83.46 | 46.61 | -8.04 | ||
Net Income, 3 Yr. CAGR % | - | 89.14 | 83.46 | 46.61 | 1.52 | ||
Normalized Net Income, 3 Yr. CAGR % | - | 81.69 | 62.12 | 55.39 | -9.19 | ||
Diluted EPS Before Extra, 3 Yr. CAGR % | - | 40.76 | 20.21 | -8.63 | -24.25 | ||
Accounts Receivable, 3 Yr. CAGR % | - | - | 177.44 | 102.41 | 153.17 | ||
Inventory, 3 Yr. CAGR % | - | -58.07 | - | - | - | ||
Net Property, Plant and Equip., 3 Yr. CAGR % | - | 9.91 | 62.94 | 58.98 | -32.73 | ||
Total Assets, 3 Yr. CAGR % | - | 186.36 | 157.58 | 68.09 | -44.83 | ||
Tangible Book Value, 3 Yr. CAGR % | - | 223.33 | 204.83 | 71.21 | -77.15 | ||
Common Equity, 3 Yr. CAGR % | - | 223.33 | 211.29 | 71.21 | -77.15 | ||
Cash From Operations, 3 Yr. CAGR % | - | 126.36 | 91.06 | 61.98 | -7.24 | ||
Capital Expenditures, 3 Yr. CAGR % | - | -28.57 | 12.53 | 120.12 | -65.89 | ||
Levered Free Cash Flow, 3 Yr. CAGR % | - | - | 107.72 | 71.98 | -13.71 | ||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | - | 107.42 | 71.9 | -13.79 | ||
Compound Annual Growth Rate Over Five Years | |||||||
Total Revenues, 5 Yr. CAGR % | - | - | - | 52.48 | 107.84 | ||
Gross Profit, 5 Yr. CAGR % | - | - | - | 74.09 | 15.95 | ||
EBITDA, 5 Yr. CAGR % | - | - | - | 60.26 | 13.16 | ||
EBITA, 5 Yr. CAGR % | - | - | - | 58.08 | 12.2 | ||
EBIT, 5 Yr. CAGR % | - | - | - | 58.17 | 12.2 | ||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | - | 61.26 | 14.97 | ||
Net Income, 5 Yr. CAGR % | - | - | - | 61.26 | 22 | ||
Normalized Net Income, 5 Yr. CAGR % | - | - | - | 59.77 | 12.11 | ||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | - | 22.97 | -13.28 | ||
Accounts Receivable, 5 Yr. CAGR % | - | - | - | - | 63.22 | ||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | - | 32.79 | -18.29 | ||
Total Assets, 5 Yr. CAGR % | - | - | - | 54.87 | 28.46 | ||
Tangible Book Value, 5 Yr. CAGR % | - | - | - | 50.83 | -11.89 | ||
Common Equity, 5 Yr. CAGR % | - | - | - | 50.83 | -11.89 | ||
Cash From Operations, 5 Yr. CAGR % | - | - | - | 76.12 | 27.02 | ||
Capital Expenditures, 5 Yr. CAGR % | - | - | - | -26.59 | -50.69 | ||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | 30.09 | ||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | 30.36 |
Select your edition
All financial news and data tailored to specific country editions
















